Maximum quantity allowed is 999
Please select the quantity
CAS RN: 101968-85-8 | Product Number: B5324
N-tert-Butylcarbamoyl-L-tert-leucine
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- (S)-2-[3-(tert-Butyl)ureido]-3,3-dimethylbutyric Acid
Product Documents:
| Size | Unit Price | Hyderabad | Japan* | Quantity |
|---|---|---|---|---|
| 1G |
₹3,800.00
|
Contact Us | 13 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | B5324 |
Purity / Analysis Method 
|
>98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__1H__2__2N__2O__3 = 230.31 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 101968-85-8 |
| Reaxys Registry Number | 14336343 |
| PubChem Substance ID | 354334535 |
| MDL Number | MFCD12796012 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Neutralization titration) | min. 98.0 % |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 182 °C(dec.) |
| Specific Rotation | -6° (C=1,AcOH) |
GHS
Related Laws:
Transport Information:
Application
A Synthetic Intermediate of Peptidic Protease Inhibitor
This product is used as a synthetic intermediate of peptidic protease inhibitor for the potential treatment of hepatic virus infection, such as boceprevir.
References
- Discovery of (1R,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection
- Synthesis and Process Optimization of Boceprevir: A Protease Inhibitor Drug
PubMed Literature
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.